Latest Headlines
-
Blackstone Life Sciences Launches Uniquity Bio To Develop Novel Medicines In Immunology & Inflammation
5/15/2024
Blackstone (NYSE:BX) today announced the launch of the Blackstone Life Sciences (“Blackstone”) portfolio company Uniquity Bio, a clinical-stage drug development company focused on immunology and inflammation.
-
Ribobay Pharma Boosts CRDMO Offerings With Cytiva’s First FlexFactory Platform For Oligonucleotides
5/15/2024
Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva’s first FlexFactory platform for oligo manufacturing.
-
Contec, Inc. Announces New Manufacturing Plant In Philippines
5/15/2024
Contec, Inc. announced that it has opened a new manufacturing plant in a Special Economic Zone in Laguna, Philippines. Contec continues to expand its global footprint and this expansion is in addition to several investments made in the past two years.
-
Germfree Announces The Appointment Of Four Independent Board Members
5/9/2024
"We are excited to welcome Dorothy, Karen, Kerry and Helga to our Board of Directors. Their counsel will guide strategic alternatives, aid Germfree in capitalizing on opportunities, and navigate future challenges. Leveraging their collective expertise, the Board will play a pivotal role in driving sustainable growth and ensuring long-term success. Germfree’s story is one of relentless innovation, unwavering commitment to quality, and profound impact on global health. We remain committed to advancing innovation and maintaining our position as a leader in critical environment equipment, cleanrooms, and laboratories. Our Board will help Germfree to capitalize on emerging trends and technological advancements, particularly in the rapidly evolving fields of cell and gene therapy," said Kevin Kyle, CEO at Germfree.
-
Germfree and Orgenesis Announce Asset Purchase And Strategic Partnership Intended To Revolutionize Cell And Gene Therapy Through Decentralized Production And Global Accessibility
5/9/2024
Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (Nasdaq: ORGS), a global leader in decentralizing cell and gene therapies (CGTs), today announced an asset purchase and strategic partnership aimed at advancing Orgenesis’ therapeutic programs and its suite of product development and GMP cell processing services. The collaboration’s goal is to transform the production of cell and gene therapies, making these vital treatments more affordable and accessible to patients worldwide.
-
CAI Announces, “Impacting Manufacturing Operations Through Quality Risk Management And Contamination Control Strategy” Event For June 10 In Maryland
5/8/2024
Join CAI on Monday, June 10th for an insightful discussion on Impacting Manufacturing Operations through Quality Risk Management and Contamination Control Strategy. Collaborate with industry experts and colleagues. Together we'll dive into how recent regulatory guidance is directly impacting day to day operations and how others are assessing, and implementing their CCS utilizing QRM.
-
CDMO Grand River Aseptic Manufacturing Announces Plans To Expand Syringe And Cartridge Capacity In Michigan
5/8/2024
Grand River Aseptic Manufacturing (“GRAM”), a leading sterile injectable contract manufacturer of biologics, small molecules, and vaccines, announces its third world-class facility in five years. At 150,000 sq. ft., the syringe and cartridge filling center will provide greater capacity for the industry’s growing biologics pipeline and the growth in advanced drug delivery systems for patient self-administration.
-
Convenience Meets Compliance: Introducing The Next-Generation Sterility Testing Pump For The Connected Lab
5/6/2024
The life science group Sartorius announces the launch of the 4th generation Sterisart® Universal pump, marking a significant innovation in the field of sterility testing. Designed for the reliable transfer of samples and media into Sterisart® canisters, this new pump meets the stringent quality and safety standards demanded by today's pharmaceutical and biotechnology industries.
-
Novartis Acquires Mariana Oncology To Advance Radiopharmaceuticals For Cancer Treatment
5/2/2024
Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, today announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments. The acquisition brings together Mariana Oncology’s innovative radiopharmaceutical pipeline and platform with the proven clinical development and commercialization expertise of Novartis.
-
Honeywell Life Science Innovation Day Announced in Milan Italy
5/2/2024
Honeywell invites you to join us for one of our Life Sciences Innovation Days, a series offered throughout the globe in 2024. We will present a variety of process innovations to support the digital transformation of life sciences manufacturing.